Insights

Niche Market Focus Martek Pharmacal Co operates within a specialized segment of pharmaceutical manufacturing, presenting an opportunity to offer tailored solutions that enhance production efficiency, compliance, and product innovation.

Growing Revenue Potential With a revenue range of 1 to 10 million dollars, there is significant room for expansion and growth through strategic partnerships, new product development, and market expansion efforts.

Technology Adoption Utilizing a modern tech stack including cloud services, MySQL, and web security tools indicates an openness to technological enhancements, signaling potential for digital transformation solutions.

Small but Agile Team A small employee base of 2-10 suggests flexibility and a quick decision-making process, ideal for pilot programs or introducing innovative products with minimal organizational resistance.

Industry Collaborations Positioned within a competitive landscape alongside industry giants, Martek Pharmacal has the chance to leverage strategic partnerships or niche collaborations to increase visibility and market share.

Martek Pharmacal Co Tech Stack

Martek Pharmacal Co uses 8 technology products and services including RSS, Cloudflare, MySQL, and more. Explore Martek Pharmacal Co's tech stack below.

  • RSS
    Content Management System
  • Cloudflare
    Content Management System
  • MySQL
    Database
  • Twemoji
    Font Scripts
  • Modernizr
    Javascript Libraries
  • reCAPTCHA
    Security
  • Bootstrap
    UI Frameworks
  • Max Mega Menu
    Widgets

Media & News

Martek Pharmacal Co's Email Address Formats

Martek Pharmacal Co uses at least 1 format(s):
Martek Pharmacal Co Email FormatsExamplePercentage
First@martekpharmacal.comJohn@martekpharmacal.com
25%
First.Last@martekpharmacal.comJohn.Doe@martekpharmacal.com
25%
F.Last@martekpharmacal.comJ.Doe@martekpharmacal.com
25%
First@martekpharmacal.comJohn@martekpharmacal.com
25%

Frequently Asked Questions

What is Martek Pharmacal Co's official website and social media links?

Minus sign iconPlus sign icon
Martek Pharmacal Co's official website is martekpharmacal.com and has social profiles on LinkedIn.

What is Martek Pharmacal Co's NAICS code?

Minus sign iconPlus sign icon
Martek Pharmacal Co's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Martek Pharmacal Co have currently?

Minus sign iconPlus sign icon
As of December 2025, Martek Pharmacal Co has approximately 4 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Of Business Development: B. B.Vice President Of Sales: J. T.Bariatric Pharmaceutical Sales: N. T.. Explore Martek Pharmacal Co's employee directory with LeadIQ.

What industry does Martek Pharmacal Co belong to?

Minus sign iconPlus sign icon
Martek Pharmacal Co operates in the Pharmaceutical Manufacturing industry.

What technology does Martek Pharmacal Co use?

Minus sign iconPlus sign icon
Martek Pharmacal Co's tech stack includes RSSCloudflareMySQLTwemojiModernizrreCAPTCHABootstrapMax Mega Menu.

What is Martek Pharmacal Co's email format?

Minus sign iconPlus sign icon
Martek Pharmacal Co's email format typically follows the pattern of First@martekpharmacal.com. Find more Martek Pharmacal Co email formats with LeadIQ.

Martek Pharmacal Co

Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees

Martek Pharmacal Co is a Pharmaceuticals company located in 1575 Route 37 W, Toms River, New Jersey, United States.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Martek Pharmacal Co's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Martek Pharmacal Co's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.